NPM1 mutation but not RUNX1 mutation or multilineage dysplasia defines a prognostic subgroup within de novo acute myeloid leukemia lacking recurrent cytogenetic abnormalities in the revised 2016 WHO classification

Am J Hematol. 2017 Jul;92(7):E123-E124. doi: 10.1002/ajh.24739. Epub 2017 May 26.
No abstract available

Publication types

  • Letter

MeSH terms

  • Chromosome Aberrations*
  • Core Binding Factor Alpha 2 Subunit / genetics*
  • Female
  • Humans
  • Leukemia, Myeloid, Acute* / classification
  • Leukemia, Myeloid, Acute* / genetics
  • Male
  • Neoplasm Proteins / genetics*
  • Nuclear Proteins / genetics*
  • Nucleophosmin
  • Retrospective Studies
  • World Health Organization

Substances

  • Core Binding Factor Alpha 2 Subunit
  • NPM1 protein, human
  • Neoplasm Proteins
  • Nuclear Proteins
  • RUNX1 protein, human
  • Nucleophosmin